EN DE

American Vanguard Corporation (AVD) Fair Value & Analysis

Basic Materials · US · Market cap $74.1M

AV American Vanguard Corporation logo American Vanguard Corporation AVD · US
Price$2.41
Fair Value$5.11
Upside+112.0%
Quality44/100
Watch American Vanguard Corporation for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -8.7% net margin
Moderate debt · negative free cash flow
Trails peers (4/12)
Narrow moat 19/100
Evidence: Medium Range $2.27 – $5.11 Share as image

Fair value as of: Jul 24, 2026

From 6 valuation models · updated 17 days ago

Share price −6.9% over the past month.

Below-average quality, screening 112% undervalued on our models.

What matters now

  • The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain.
  • A fairly wide model range ($2.27 to $5.11) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$25.42 $2.06 Fair Value $5.11 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.

How to read this chart

60‑month range $2.06 – $25.42 · fair‑value band $2.27 – $5.11 · the $2.41 price screens below the $5.11 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 24, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

American Vanguard Corporation (AVD) currently trades at $2.41, while our model-based Fair Value estimate is $5.11, implying the stock looks roughly 112.0% undervalued today. The Quality Score stands at 44/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, American Vanguard Corporation generated revenue of $523M at a net margin of -8.7%. Revenue grew 6.7% year over year. It earns a return on equity of -21.9%. Net debt stands at $179M. Fundamentals as of Jul 24, 2026

Our scenario range runs from $2.27 (bear case) to $5.11 (bull case); at $2.41, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 59% below its 52-week high and 18% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at 112%, AVD screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Gordon GGM $0.6100 $1.02 $1.33 70
DDM Multi-Stage $0.6100 $0.9600 $1.10 61
EV/EBITDA $2.88 $5.72 $8.56 54
All 6 models by family
Dividend Discount
Gordon GGM $0.6100 $1.02 $1.33 70
DDM Multi-Stage $0.6100 $0.9600 $1.10 61
Multiples
EV/EBIT $1.09 $2.77 53
EV/EBITDA $2.88 $5.72 $8.56 54
EV/Revenue $0.6100 $2.49 43
Asset-Based
NCAV (Graham) $3.36 $4.51 $6.73 50

Widest divergence: Asset-Based ($4.51) versus Dividend Discount ($0.9600). Highest evidence: Gordon GGM (70).

Notify me when AVD reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $523M
Revenue growth (YoY) +6.7%
Net margin -8.7%
Return on equity -21.9%
Free cash flow −$25.3M FY2025
Operating margin 4.3%
More key figures
EPS (TTM) $-1.59
EPS growth (YoY) -17.6%
Net debt $179M FY2025

Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 44/100

Of which business quality 40 · Market factors (momentum, volatility) 12

Profitability 21
Margins and returns on capital today
Quality Growth 59
Are margins and returns improving?
Cashflow 1
Earnings quality: real cash, not paper profit
Fin. Strength 24
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 14
Calm price path (market factor)
Momentum 16
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally.

Full company description

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

American Vanguard Corporation reported revenue of $515M in FY2025 versus $558M in FY2021, a compound −2.0%/yr. Reported net income was −$49.9M in FY2025.

Growth Quality 10/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
$515M
Latest YoY
−5.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−5.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.3%
Avg. growth/yr (39Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.3%
Revenue −2.0%/yr
FY21 $558M
FY22 $610M
FY23 $579M
FY24 $547M
FY25 $515M
Net income
FY21 $18.6M
FY22 $27.4M
FY23 $7.5M
FY24 −$126M
FY25 −$49.9M

Watch AVD: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "American Vanguard Corporation Fair Value". https://www.fairvalue-calculator.com/stock/AVD

Peer Group

Agricultural Inputs · 179 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 44 · Below median
Fair Value upside +112% · Top 25%
Return on assets 1% · Below median
Net margin (TTM) -9% · Bottom 25%
Operating margin (TTM) 4% · Below median
Revenue growth 7% · Below median
Debt / equity 0.90× · Higher than 75% of peers

Valuation Multiples vs Agricultural Inputs median · lower = cheaper

P/B 0.39× · Cheaper than 75% of peers
P/S (TTM) 0.14× · Cheaper than 75% of peers
EV/EBITDA 7.8× · Pricier than median
PEG 0.25× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 21
FUTURE 34 · sector 37
PAST 0 · sector 24
HEALTH 55 · sector 97
DIVIDEND 0 · sector 33

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $86.07 $27.81 -68%
Nutrien Ltd NTR C$94.23 C$81.69 -13%
Qinghai Salt Lake Industry Co 000792 ¥24.93 ¥21.26 -15%
CF Industries Holdings CF $119.19 $161.00 +35%
SABIC Agri-Nutrients Company 2020 122.90 SAR 127.31 SAR +4%
Yara International ASA YAR kr 451.30 kr 67.25 -85%
Yunnan Yuntianhua Co 600096 ¥30.17 ¥42.12 +40%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥42.59 ¥38.01 -11%
Coromandel International Limited COROMANDEL ₹2,034 ₹1,129 -44%
UPL Limited UPL ₹594.75 ₹387.06 -35%

Compare American Vanguard Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is American Vanguard Corporation (AVD) overvalued or undervalued?
As of Jul 24, 2026, our model estimates a fair value of $5.11 versus a price of $2.41, about +112% (undervalued).
What is the fair value of AVD?
Our model-based fair value for American Vanguard Corporation is $5.11 (as of Jul 24, 2026), built from audited fundamentals. The current price is $2.41.
What is the quality score of AVD?
American Vanguard Corporation has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of American Vanguard Corporation (AVD)?
American Vanguard Corporation reported trailing-twelve-month revenue of about $523M (latest available figure, as of Jul 24, 2026).
What is the net profit margin of AVD?
The net profit margin of American Vanguard Corporation is about -8.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track American Vanguard Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.